Home > R&D Offer > In Vivo Preclinical Studies

In Vivo Preclinical Studies

As Part of its In Vivo Preclinical Offer, CALYM Offers in Particular to:

  • define the preliminary safety and efficacy profile of drug candidates to optimize the cost-effectiveness of regulatory studies in view of clinical conduct
  • establish correlations between genetic analyzes and clinical data
  • carry out pharmacology studies
  • study activation mechanisms of the immune system

Many lymphoma mouse models are available in our institute: transgenic models, xenografts, PDX ...

New innovative in vivo models closer to the biology can also be developed by our experts.

► Find out more information about our in vivo models!


Contact us:+33 (0)4 72 24 41 71, by e-mail
or by submitting your question in the contact form